Recent News

Galinpepimut-S Alongside Opdivo Improves Survival in Mesothelioma Patients

February 16, 2024

Sellas Life Sciences recently reported results from its Phase I clinical trial showing that survival was improved in pleural mesothelioma patients due to its treatment. The trial looked at the[…]

Read More

Breath Test Could Improve Diagnosis of Mesothelioma

February 9, 2024

A new way to diagnose mesothelioma may have been discovered. Researchers have found that the exhaled breath of patients could have the potential to be a screening tool for malignant[…]

Read More

Occupational and Environmental Exposure to Asbestos Reduces Longevity in Patients

February 2, 2024

Mesothelioma is a hard cancer to treat that is mainly caused by asbestos. People with this cancer typically do not live very long after diagnosis, but some people live longer[…]

Read More

Altered CAR-T Cell Therapy for the Treatment of Mesothelioma

January 26, 2024

Immunotherapy is an innovative and groundbreaking way to treat cancer. It uses the immune system to fight and kill cancer cells. One immunotherapy treatment that is showing good results for[…]

Read More

Radiation and Immunotherapy Combination Improves Survival in Lung Cancer Patients

January 19, 2024

A new study looking at low dose radiation and immunotherapy is showing promising results for non-small cell lung cancer. Patients treated with the combination had higher progression free survival compared[…]

Read More

ADI-PEG 20 is Being Tested on Non-Epithelioid Mesothelioma

January 12, 2024

Polaris Group recently announced an application for a rolling submission of a new mesothelioma treatment. The Biologic License Application is the first step in becoming approved by the Food and[…]

Read More

CARD is Working on New Articles to be Released in 2024

January 5, 2024

The Center for Asbestos Related Disease is working on new research articles that will be released throughout this year. They will be focusing on asbestos and autoimmune disease. The articles[…]

Read More

Pembrolizumab and Chemotherapy Improve Survival in Patients

December 15, 2023

Pleural mesothelioma, a cancer mainly caused by asbestos, is a hard cancer to treat. Diagnosis usually occurs when it is in a late stage, leading to limited treatment options. New[…]

Read More

CIRT Radiation Therapy Beneficial for Lung Cancer Patients

December 8, 2023

Surgery is usually the first choice for patients and doctors for the treatment of early-stage cancer. There are other options though like radiotherapy. A special type of radiotherapy called Carbon-ion[…]

Read More

Checkmate743 Showed Higher Toxicity in a Real World Setting

December 1, 2023

A group of Australian patients receiving Checkmate743 therapy saw higher levels of toxicity compared to CheckMate743 clinical trial patients. Checkmate743 consists of a dual treatment of ipilimumab and nivolumab and[…]

Read More